Member State to which the notification was sent
Date of acknowledgement from the Member State Competent Authority
Title of the Project
Field experimentation of a genetically modified maize. Functional validation of a gene involved in nitrogen efficiency and grain filling.
Proposed period of release:
01/04/2005 to 30/11/2008
Name of the Institute(s) or Company(ies)
3. Is the same GMPt release planned elsewhere in the Community?
Has the same GMPt been notified elsewhere by the same notifier?
If yes, notification number(s):
Genetically modified plant
Complete name of the recipient or parental plant(s)
hybrids between A188 and a breeding line
2. Description of the traits and characteristics which have been introduced or modified, including marker genes and previous modifications:
Better nitrogen assimilation by the plant, increase of essential amino acid content in the grain.
Transgenic plants contain either the bar gene conferring resistance to glufosinate or kanamycine, respectively.
3. Type of genetic modification:
In case of insertion of genetic material, give the source and intended function of each constituent fragment of the region to be inserted:
Actin1 and first intron: Oryza sativa, non coding regulatory sequence
CsVMV promoter : Cassava vein mosaic virus, non coding regulatory sequence
Actin1 first intron: Oryza sativa, non coding regulatory sequence
Bar (pat) : Streptomyces hygroscopicus, coding sequence
nos 3’ : Agrobacterium tumefaciens, non coding regulatory sequence
nptII: Escherichia coli, coding sequence
Ds 5’ / Ds 3’: Zea mays, non coding sequence
Gs-1b (Gln1-3): Zea mays, coding sequence
RB / LB: Agrobacterium tumefaciens, non-coding sequence
6. Brief description of the method used for the genetic modification:
Agrobacterium tumefaciens mediated transformation.
7. If the recipient or parental plant is a forest tree species, describe ways and extent of dissemination and specific factors affecting dissemination:
1. Purpose of the release:
Production of plant and grain under agronomic conditions. Total biomass production evaluation under different nitrogen fertilization conditions. Functional validation of a maize gene.
2. Geographical location of the site:
Center of France (Puy-de-Dôme, Auvergne)
South-west of France (Haute-Garonne, Midi-Pyrénées)
For the first year
3. Size of the site (m2):
Auvergne 1 800 sq mt (2005 to 2008),
Midi-Pyrénées 1 800 sq mt (2005 to 2008),
For each location, the size corresponds to transgenic plants only, checks and border rows not included)
4. Relevant data regarding previous releases carried out with the same GM-plant, if any, specifically related to the potential environmental and human health impacts from the release:
Second release for these transformation events, first release has been destroyed by activists.
Environmental Impact and Risk Management
Summary of the potential environmental impact from the release of the GMPts:
None of the introduced traits has potential effects to modify the plant persistency in the environment(plants will not be sprayed with herbicide or antibiotic). There is no wild relatives of corn in Europe and outcrossing are not possible. In this experiment, there is no modification of the direct or indirect interactions between the modified plants and target or non-target organisms. There is no expected effects on human health and on animal health. Plants will not be used as food. There is no short-term possible effect on specific cultivation management and harvesting techniques.
Potential environmental impact considered minimal, given the conditions of the field trial (location, absence pollen production, presence of 4 rows of non-transgenic maize plants around the field trial, minimal contacts with fauna and flora, absence of wild relatives of maize species in the release areas...).
Brief description of any measures taken for the management of risks:
Release sites located in intensive agriculture areas. Collection of seeds, destruction of plant vegetative material.
Monitoring and destruction of volunteers during one year following the end of experiment.
Summary of foreseen field trial studies focused to gain new data on environmental and human health impact from the release:
European Commission administrative information
Consent given by the Member State Competent Authority: